Company / Cost of Revenue
Baxter International Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$7.9B
FY2025
5-year range
$6.2B / $7.9B
FY2021-FY2025
Trend
+18.2%
vs FY2024
Sector context
#16 of 113
Health Care
What the data says
Baxter International's cost of revenue of $7.9B is higher than 86% of companies in the Health Care sector (FY2025). Cost of Revenue has fluctuated over the past 10 years, ranging from $6.1B in FY2019 to $7.9B in FY2025.
Based on SEC 10-K filings.
$7.9B in FY2025 with a 5-year CAGR of +2.1%. Top quartile in the Health Care sector.
Increased from $6.2B to $7.9B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +6.5%
- 5-Year CAGR
- +2.1%
- 10-Year CAGR
- -
Sector benchmark
-30.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.1%, indicating consistent growth.
- In FY2025, cost of revenue increased 18.2% year-over-year.
- Ranks #16 out of 113 companies in the Health Care sector.
- Lowest cost of revenue in the period was in FY2019.
Company context
Key Data Points
- Negative profit margin: -6.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.9B | +18.2% |
| FY2024 | $6.7B | +7.1% |
| FY2023 | $6.2B | -4.6% |
| FY2022 | $6.5B | -12.4% |
| FY2021 | $7.4B | +4.8% |
| FY2020 | $7.1B | +16.0% |
| FY2019 | $6.1B | -3.6% |
| FY2018 | $6.3B | +3.8% |
| FY2017 | $6.1B | -0.5% |
| FY2016 | $6.1B | +5.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026